Ghent University Academic Bibliography

Advanced

Severity of doxorubicin-induced small intestinal mucositis is regulated by the TLR-2 and TLR-9 pathways

Agnieszka Kaczmarek UGent, Brigitta Brinkman UGent, Liesbeth Heyndrickx UGent, Peter Vandenabeele UGent and Dmitri Krysko UGent (2012) JOURNAL OF PATHOLOGY. 226(4). p.598-608
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
SIGNALING PATHWAYS, inflammation, TOLL-LIKE RECEPTORS, GLYCOGEN-SYNTHASE KINASE-3, VERSUS-HOST-DISEASE, MYELOABLATIVE THERAPY, INNATE IMMUNITY, EPITHELIAL-CELLS, ileitis, apoptosis, small intestine damage, chemotherapy-induced mucositis, IN-VIVO, INFLAMMATION, APOPTOSIS
journal title
JOURNAL OF PATHOLOGY
J. Pathol.
volume
226
issue
4
pages
598 - 608
Web of Science type
Article
Web of Science id
000299779300005
JCR category
PATHOLOGY
JCR impact factor
7.585 (2012)
JCR rank
3/77 (2012)
JCR quartile
1 (2012)
ISSN
0022-3417
DOI
10.1002/path.3009
project
Ghent researchers on unfolded proteins in inflammatory disease (GROUP-ID)
project
Ghent researchers on unfolded proteins in inflammatory disease (GROUP-ID)
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
2049927
handle
http://hdl.handle.net/1854/LU-2049927
date created
2012-02-28 17:21:55
date last changed
2014-05-12 10:58:54
@article{2049927,
  author       = {Kaczmarek, Agnieszka and Brinkman, Brigitta and Heyndrickx, Liesbeth and Vandenabeele, Peter and Krysko, Dmitri},
  issn         = {0022-3417},
  journal      = {JOURNAL OF PATHOLOGY},
  keyword      = {SIGNALING PATHWAYS,inflammation,TOLL-LIKE RECEPTORS,GLYCOGEN-SYNTHASE KINASE-3,VERSUS-HOST-DISEASE,MYELOABLATIVE THERAPY,INNATE IMMUNITY,EPITHELIAL-CELLS,ileitis,apoptosis,small intestine damage,chemotherapy-induced mucositis,IN-VIVO,INFLAMMATION,APOPTOSIS},
  language     = {eng},
  number       = {4},
  pages        = {598--608},
  title        = {Severity of doxorubicin-induced small intestinal mucositis is regulated by the TLR-2 and TLR-9 pathways},
  url          = {http://dx.doi.org/10.1002/path.3009},
  volume       = {226},
  year         = {2012},
}

Chicago
Kaczmarek, Agnieszka, Brigitta Brinkman, Liesbeth Heyndrickx, Peter Vandenabeele, and Dmitri Krysko. 2012. “Severity of Doxorubicin-induced Small Intestinal Mucositis Is Regulated by the TLR-2 and TLR-9 Pathways.” Journal of Pathology 226 (4): 598–608.
APA
Kaczmarek, Agnieszka, Brinkman, B., Heyndrickx, L., Vandenabeele, P., & Krysko, D. (2012). Severity of doxorubicin-induced small intestinal mucositis is regulated by the TLR-2 and TLR-9 pathways. JOURNAL OF PATHOLOGY, 226(4), 598–608.
Vancouver
1.
Kaczmarek A, Brinkman B, Heyndrickx L, Vandenabeele P, Krysko D. Severity of doxorubicin-induced small intestinal mucositis is regulated by the TLR-2 and TLR-9 pathways. JOURNAL OF PATHOLOGY. 2012;226(4):598–608.
MLA
Kaczmarek, Agnieszka, Brigitta Brinkman, Liesbeth Heyndrickx, et al. “Severity of Doxorubicin-induced Small Intestinal Mucositis Is Regulated by the TLR-2 and TLR-9 Pathways.” JOURNAL OF PATHOLOGY 226.4 (2012): 598–608. Print.